Skip to content

ROCKWELL MEDICAL, INC.: 10-K filed 2017-03-15

What ROCKWELL MEDICAL, INC. reported in its annual report filed 2017-03-15 (fiscal FY 2016): 39 published measures, 151 facts as tagged in accession 0001558370-17-001846.

This filing

Form
10-K (annual report)
Filed
2017-03-15
Fiscal period
fiscal FY 2016
Accession
0001558370-17-001846 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ROCKWELL MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-12-3183,153,638USD
At 2015-12-3187,822,125USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-12-3152,956,299USD
At 2015-12-3162,319,822USD
At 2014-12-3168,702,794USD
At 2013-12-31595,539USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-12-3117,180,594USD
At 2015-12-3131,198,182USD
At 2014-12-3165,800,451USD
At 2013-12-3111,881,451USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-5,054,298USD92
2016-01-01 to 2016-12-31-19,802,916USD366
2016-07-01 to 2016-09-30-4,563,262USD92
2016-04-01 to 2016-06-30-5,361,146USD91
2016-01-01 to 2016-03-31-4,824,210USD91
2015-10-01 to 2015-12-31-5,769,956USD92
2015-01-01 to 2015-12-31-14,420,450USD365
2015-07-01 to 2015-09-30-2,414,553USD92
2015-04-01 to 2015-06-30-2,536,747USD91
2015-01-01 to 2015-03-31-3,699,194USD90
2014-01-01 to 2014-12-31-21,327,157USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-12,452,638USD366
2015-01-01 to 2015-12-31-16,240,910USD365
2014-01-01 to 2014-12-314,257,778USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-01-01 to 2016-12-3180,161USD366
2015-01-01 to 2015-12-312,780,187USD365
2014-01-01 to 2014-12-3158,469,815USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-1,644,440USD366
2015-01-01 to 2015-12-31-21,141,546USD365
2014-01-01 to 2014-12-31-8,808,593USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-12-31-214,341,092USD
At 2015-12-31-194,538,176USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2016-01-01 to 2016-12-3150,676,180shares366
2015-01-01 to 2015-12-3150,068,129shares365
2014-01-01 to 2014-12-3141,404,999shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2016-01-01 to 2016-12-3150,676,180shares366
2015-01-01 to 2015-12-3150,068,129shares365
2014-01-01 to 2014-12-3141,404,999shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-0.39USD/shares366
2015-01-01 to 2015-12-31-0.29USD/shares365
2014-01-01 to 2014-12-31-0.52USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-0.39USD/shares366
2015-01-01 to 2015-12-31-0.29USD/shares365
2014-01-01 to 2014-12-31-0.52USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-01-01 to 2016-12-31404,527USD366
2016-01-01 to 2016-03-31404,527USD91
2015-01-01 to 2015-12-310USD365
2014-01-01 to 2014-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-12-311,391,575USD
At 2015-12-311,646,568USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-01-01 to 2016-12-3110,346,284USD366
2015-01-01 to 2015-12-318,887,977USD365
2014-01-01 to 2014-12-3110,094,685USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-5,262,209USD92
2016-01-01 to 2016-12-31-20,208,729USD366
2016-07-01 to 2016-09-30-4,752,109USD92
2016-04-01 to 2016-06-30-5,588,166USD91
2016-01-01 to 2016-03-31-4,606,245USD91
2015-10-01 to 2015-12-31-6,063,194USD92
2015-01-01 to 2015-12-31-15,102,326USD365
2015-07-01 to 2015-09-30-2,571,225USD92
2015-04-01 to 2015-06-30-2,654,898USD91
2015-01-01 to 2015-03-31-3,813,009USD90
2014-01-01 to 2014-12-31-17,559,101USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-12-3178,509,195USD
At 2015-12-3184,626,316USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-12-3110,145,602USD
At 2015-12-318,091,451USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-12-315,858,234USD
At 2015-12-313,995,216USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2016-12-31920,745USD
At 2015-12-31920,745USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-12-316,393,228USD
At 2015-12-315,046,733USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-12-3112,141,072USD
At 2015-12-317,871,780USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-10-01 to 2016-12-311,988,183USD92
2016-01-01 to 2016-12-316,752,518USD366
2016-07-01 to 2016-09-301,579,881USD92
2016-04-01 to 2016-06-301,489,528USD91
2016-01-01 to 2016-03-311,694,926USD91
2015-10-01 to 2015-12-312,056,148USD92
2015-01-01 to 2015-12-318,937,854USD365
2015-07-01 to 2015-09-302,503,406USD92
2015-04-01 to 2015-06-302,065,957USD91
2015-01-01 to 2015-03-312,312,343USD90
2014-01-01 to 2014-12-318,545,213USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2016-10-01 to 2016-12-316,049,663USD92
2016-01-01 to 2016-12-3121,120,901USD366
2016-07-01 to 2016-09-305,070,127USD92
2016-04-01 to 2016-06-305,014,370USD91
2016-01-01 to 2016-03-314,986,741USD91
2015-10-01 to 2015-12-316,089,606USD92
2015-01-01 to 2015-12-3119,078,867USD365
2015-07-01 to 2015-09-303,827,904USD92
2015-04-01 to 2015-06-303,835,596USD91
2015-01-01 to 2015-03-315,325,761USD90
2014-01-01 to 2014-12-3118,320,720USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-10-01 to 2016-12-311,200,729USD92
2016-01-01 to 2016-12-315,840,346USD366
2016-07-01 to 2016-09-301,261,863USD92
2016-04-01 to 2016-06-302,063,324USD91
2016-01-01 to 2016-03-311,314,430USD91
2015-10-01 to 2015-12-312,029,736USD92
2015-01-01 to 2015-12-314,961,313USD365
2015-07-01 to 2015-09-301,246,727USD92
2015-04-01 to 2015-06-30885,259USD91
2015-01-01 to 2015-03-31799,591USD90
2014-01-01 to 2014-12-317,783,594USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-12-3151,527,711shares
At 2015-12-3151,501,877shares
At 2014-12-3150,284,007shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2016-12-31-902,548USD
At 2015-12-31-915,496USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-12-3111,066,926USD
At 2015-12-3110,940,833USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-12-319,675,351USD
At 2015-12-319,294,265USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2016-12-314,382USD
At 2015-12-31165,657USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-12-31501,187USD
At 2015-12-31462,839USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-12-314,210,151USD
At 2015-12-313,831,356USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-5,054,298USD92
2016-01-01 to 2016-12-31-19,398,389USD366
2016-07-01 to 2016-09-30-4,563,262USD92
2016-04-01 to 2016-06-30-5,361,146USD91
2016-01-01 to 2016-03-31-4,419,683USD91
2015-10-01 to 2015-12-31-5,769,956USD92
2015-01-01 to 2015-12-31-14,420,450USD365
2015-07-01 to 2015-09-30-2,414,553USD92
2015-04-01 to 2015-06-30-2,536,747USD91
2015-01-01 to 2015-03-31-3,699,194USD90
2014-01-01 to 2014-12-31-21,327,157USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2016-01-01 to 2016-12-31-19,789,968USD366
2015-01-01 to 2015-12-31-15,138,277USD365
2014-01-01 to 2014-12-31-21,557,245USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-01-01 to 2016-12-31601,093USD366
2015-01-01 to 2015-12-31655,265USD365
2014-01-01 to 2014-12-31829,292USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-01-01 to 2016-12-31762,368USD366
2015-01-01 to 2015-12-31822,294USD365
2014-01-01 to 2014-12-31996,321USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2016-01-01 to 2016-12-31404,527USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-12-316,095,846USD366
2015-01-01 to 2015-12-313,951,595USD365
2014-01-01 to 2014-12-311,120,537USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-12-311,863,018USD366
2015-01-01 to 2015-12-31-1,299,299USD365
2014-01-01 to 2014-12-31-3,391,638USD365

Inspect the source

Entity
ROCKWELL MEDICAL, INC. / CIK 0001041024
Captured
2026-09-20T05:15:52.429Z
SEC response SHA-256
88e8b83e4e95fda016bcc9a5dced4522c975c40fff65ebdbda5ac42b28ba4fb6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001041024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))